Conference Information

Welcome Message

We are pleased to announce the “6^th International Confgress on Nanomedicine and Nanotechnology” Scheduled on March 27-29, 2023 in London, UK. It has the pleasure to welcome all researchers, professors, students and experts from all over the globe to take part in the Clinical Immunology Conferences 2023.

Clinical Immunology Conferences 2023 will offer a wide range of interesting topics with keynote lectures, speaker sessions, workshops, poster sessions and young researchers forum.

You will get the chance to meet immensely knowledgeable people from all around the world, present your own research, and communicate with your colleagues at Clinical Immunology Conferences 2023.

We are sure the Clinical Immunology conferences 2023 will provide you with some memorable experiences.

Market Analysis

The global immunology market size is USD 85.74 billion by 2020. The global impact of COVID-19 is unprecedented and staggering, with immunology drugs negatively impacting demand at all. regions during the pandemic. Based on our analysis, the global market growth is 4.2% lower in 2020 than the average annual growth of 201-2020. The market is expected to grow from USD 92.00 billion in 2021 to USD 158.69 billion in 2028 at a CAGR of 8.1% during 2021-2028. The CAGR spike is due to market demand and this growth rate, which returns to pre-pandemic levels once the pandemic is over. Drugs or immune agents that alter the immune response, by strengthening or suppressing the immune system. They are used to fight infections, prevent, or treat certain autoimmune or immune diseases.

Increasing awareness of immune diseases in developing and developed countries and increasing prevalence of immune disorders due to environmental factors are the main reasons driving the growth of the global market. Furthermore, existing market players operating in the global market are focusing on continuously innovating and upgrading their product portfolio to deliver better treatment outcomes for patients. This is expected to increase the growth rate of the market during the forecast period.

Market Drivers

In addition, the global immunology market is growing thanks to the availability of various drugs that have been approved by the regulatory authorities and the trends in improving clinical efficacy for new drug approval. The high prevalence of immune disorders is continuing to drive the market. The growing number of successful clinical trials due to environmental factors and the need for biologics are driving companies to invest in the development of effective and affordable pseudo-biological drugs and biosimilars. In addition, the increasing cases of immune diseases around the world due to the growing geriatric population and the adoption of sedentary lifestyle are driving the bull market. In addition, increasing R&D activities in life sciences and biology including immunology drugs will aid the growth of the market. In addition, growing support from government agencies and FDA approval for clinical trials are expected to enhance market turnover.

Immunotherapy is used to stimulate the immune system to fight disease, as in the case of allergies, or to slow down the immune system, such as an autoimmune disease. In addition, more and more cases of organ transplants requiring immunosuppressive drugs because new organs in the body are attacked by the immune system and need time to adapt are creating prospects for the market

Immunology market segmentation

By Drug-Class

The monoclonal antibody segment is expected to dominate the market during the forecast period due to the clinical efficacy of the procedure and the popularity of drugs such as adalimab, as well as its ability to treat some rare diseases. A protein made in the laboratory to bind to specific targets in the body, such as antigens on the surface of cancer cells, is a monoclonal antibody that can enhance, restore, which modifies or mimics the immune system's attack on unwanted cells. In addition, monoclonal antibodies are more likely to receive approval from government agencies due to their relatively low risk, prompting further segment expansion.

The immunosuppressive drug segment is also expected to grow significantly due to increased R&D activities, presence of key market participants, government approvals, adoption rate effectiveness and efficiency of the drug. Immunosuppressants are powerful drugs that prevent your immune system from damaging healthy cells and tissues because sometimes the immune system mistakenly attacks healthy cells and tissues. It has helped fight disease-causing infections, slow or stop this immune response, and prevent rejection in people who have had organ and stem cell transplants.

By Disease Indication

The rheumatoid arthritis segment is expected to dominate the market during the forecast period due to the prevalence of rheumatoid arthritis in the world. A chronic inflammatory disorder that affects many joints because the body's immune system attacks internal tissues or organs in severe cases, causing painful inflammation, bone wear, and joint deformity in the body. long time. It is treated with a type of medicine called an anti-allergic, which has no cure for rheumatoid arthritis.

Psoriatic arthritis is also believed to be showing promising development due to the increasing number of cases of psoriatic arthritis and the increased global demand for its treatment.

By Distribution Channel

The hospital pharmacy segment is expected to dominate the market during the forecast period due to the high reputation hospitals, well-developed infrastructure and wide reach. In addition, hospitals offer different drugs on demand and have a large pool of trusted patients and specialists, driving the growth of the segment.

Regional Analysis

The immunology market in North America is expected to dominate the market due to well-developed healthcare infrastructure, superior reimbursement practices, large financial investment potential due to chronic morbidity and mortality. Increasing availability, availability of good healthcare infrastructure, greater number of home healthcare facilities and higher patient diagnosis rates will lead to the adoption of free medicines. region, driving the immunology market, coupled with high diagnostic rates, easy access to immunotherapy, adoption of advanced immunotherapy treatments, and affordability drugs in countries such as the United States and Canada.

The immunology market in the euro area is expected to witness significant growth due to the increasing prevalence of chronic diseases such as rheumatoid arthritis, favourable government policies, well priced and easy to use, given that there are around 400,000 people in the UK. people with rheumatoid arthritis according to the British Society of Immunology. Latin America, the Middle East and Africa are expected to grow at a relatively slower rate due to a developing healthcare infrastructure and a lack of favourable reimbursement policies

The Asia Pacific Immunology market is also anticipated to grow at a rapid rate due to increased awareness, increased prevalence of chronic and autoimmune diseases, and easy accessibility. , an increase in drug approvals, a growing economy, and many government initiatives in countries like China, India, Korea, Japan, and more. In addition, the market can also benefit from the rapid growth of the immunotherapy market due to the presence of a large group of patients in the region.

Metrics

Pulsus Group is one of the world's most distinguished organisers of scientific conferences, displaying its individuality in all areas of science, technology and business. One element of the success of any conference series, in particular, depends on how far it reaches the online community. Having a web audience is crucial to making an international gathering a huge success, be it research, science, or industry.

Research staff, academics, research institutes, industrialists, and students in the field of immunology are the main participants, showing an intense desire to attend the clinical immunology conferences 2023 hosted by Pulsus Conferences. The conference-supported formulations, Clinical Immunology, and healthcare exhibit a significant number of unique visitors and page views that have proven to be a resounding success. Pulsus pushes its boundaries by tracking every conference that takes place on the respective conference web pages and its official social media accounts. So, this means the participation of the international scientific and industrial communities to come and experience the package of conferences, discussions, product exhibitions, and alliances.

Scientific Tracks

Session 01: Immunotherapy

Immunotherapy is a diagnostic procedure that involves either strengthening or weakening the immune system. Immunotherapy is one of the most widely utilised cancer treatments. Activation immunotherapies and suppression immunotherapies are the two forms of immunotherapies. Immunotherapies have been shown to be effective in treating a variety of tumours. Caner immunotherapies are largely biological, meaning they involve compounds derived from live creatures. Immunotherapy for cancer includes checkpoint inhibitors, adoptive cell transfer, monoclonal antibodies, and others.

Cancer Immunotherapy
Oral Immunotherapy
Immunomodulators
Antibody treatment for humanization

Associated Conferences

Related Associations

American Association of Immunologists | The American Association for Cancer Research | American Autoimmune Related Diseases Association | American Academy of Allergy, Asthma and Immunology | Association Argentina de Alergia e Inmunologia | European Academy of Allergology and Clinical Immunology (EAACI) | Latin American Association of Immunology (ALAI)

Associated Journals

Associated Societies

Session 02: Healthcare

The organised provision of medical care to persons and communities is referred to as healthcare. Businesses that provide medical services, manufacture medical equipment or medications, provide medical insurance, or otherwise enable the delivery of healthcare to patients make up the healthcare industry. Healthcare, because of its vastness and diversity, welcomes new workers with a wide range of talents, interests, and personalities. People who work in this area, on the whole, have a desire to help others and academic interests in math and science.

Associated Conferences

Related Associations

European Academy of Allergology and Clinical Immunology (EAACI) | American Association of Immunologists | Association Argentina de Alergia e Inmunologia | Latin American Association of Immunology (ALAI) | The American Association for Cancer Research | American Academy of Allergy, Asthma and Immunology | American Autoimmune Related Diseases Association

Associated Journals

Associated Societies

Session 03: Clinical Immunology

Clinical immunology has grown from serological testing for the presence of antigens to a multidimensional discipline that employs a variety of traditional techniques as well as several newer, more sensitive assay technologies. However, it still entails assessing the patients' immune systems and, as a result, their ability to respond to antigenic stimuli. With the advancement of technology, new instruments have been developed to diagnose infectious, autoimmune, and allergy illnesses.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 04: Immune Disorders

Cells, tissues, and organs make up the system, which aids the body in fighting infections and other ailments. Immune disease is a condition that affects or causes the system to malfunction. Autoimmune illness occurs when the immune system becomes overactive, causing the body to attack and damage its own tissues.

• Depending on whether immune system components are compromised

• Whether the immune system is overactive or underactive

• Whether the illness is hereditary or acquired

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 05: Viral Immunity: Basic Mechanisms and Therapeutic Applications

Viruses infect millions of people each year, causing significant illness and posing a public health danger worldwide. Limiting the impact of viral infection needs a multi-layered understanding of viral immunity, from basic research on viral identification and host immune response to clinical applications of new antiviral and host-targeted medicines and vaccines. Despite recent advances, the mechanisms underlying rapid host healing as well as severe and fatal sickness outcomes remain unknown.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 06: Autoimmune Disorder

An autoimmune condition is an uncommon or common immune reaction to a working part. These diseases will have pathological characteristics that identify them as autoimmune disorders. Damage or eradication of tissues when an aberrant immune reaction occurs, changed organ growth, and altered organ function, depending on the position of the disease, are examples of such impacts. The signs and symptoms of an illness can vary depending on its classification.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 07: Vaccination and Immunisation

Vaccination is the delivery of a vaccine into the body. Immunisation is the process that occurs within the body shortly after a vaccine. Immunization works by boosting the immune system's ability to fight illnesses. The immune system of a vaccinated person will respond more efficiently to certain infections if they are exposed to them.

• Inactivated vaccines

• Live-attenuated vaccinations

• vaccinations with conjugates

• Vaccines against toxoids

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 08: Antibodies as drugs

Antibody-Medication Conjugates (ADCs) are a new class of very effective biological medicines that are created by permanently or labile linking a small molecule anticancer drug or another therapeutic agent to an antibody. The antibody is designed to recognise a specific antigen found only on target cells. It causes the antibody and medication to be internalised when it binds to a cell. This maximises efficacy while avoiding systemic exposure and negative effects.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 09: Immunometabolism at the Crossroads of Obesity and Cancer

This is supported by our understanding of immunometabolic pathways that span patients with infection and cancer. Data from case series and retrospective investigations, on the other hand, do not provide a consistent conclusion, since data from China show an increased incidence of COVID-19, while data from the US and Italy show a prevalence of COVID-19 in cancer patients that is comparable to the general population. In the most severe cases, both cancer and COVID-19 exploit different patterns of macrophage activation to speed up disease progression.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 10: Advances in Checkpoints Immunology from Autoimmunity to Oncology to Infectious Diseases

Patients with cancer and active autoimmune disorders (ADs) have been excluded from immunotherapy clinical trials because of the significant risk of serious adverse events as a result of their preexisting ADs deteriorating. According to an increasing body of research, immune-checkpoint inhibitors (ICIs) may be safe and effective in this patient population. On the other hand, baseline corticosteroids and other nonselective immunosuppressants have a negative influence on drug efficacy, however retrospective and case report data suggest that specialised immunosuppressants may not have the same effect.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 11: Cancer Immunotherapy: Decoding the Cancer Immunity Interactome

Cancer is a collection of diseases in which cells behave abnormally and reproduce rapidly, eventually spreading to other parts of the body. Cancer cells become so changed that immune cells recognise them as alien pathogens and mount a specific immune response against them. Furthermore, cancer cells, like viruses, can evade immune surveillance and suppress anti-tumour immune responses. The investigation and regulation of this dynamic interaction between cancer and immune cells has laid the foundation for a novel cancer therapy method.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 12: Next Generation HIV Vaccines & Therapies

Antiretroviral therapy could be replaced with therapeutic vaccines and broadly neutralising antibodies (bNAbs). Although therapeutic vaccinations have been proven to temporarily lower viral load during analytic treatment interruptions (ATIs), none have been able to achieve long-term remission. It may be useful to combine vaccination efficacy with latency reversal medicines and immune modulators. bNAbs are being explored as a viable strategy to achieve long-term virologic control in the absence of antiretroviral therapy. To maximise overall coverage breadth and efficacy while limiting resistance formation, antibody combinations are required. The next generation of antibodies includes engineered bispecific and trispecific antibodies that target two or three different viral sites.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 13: Allergy and Inflammation

Inflammation is a part of the body's heightened biological response to harmful stimuli such as pathogens, damaged cells, or irritants, and it can be a protective response involving immune cells, blood vessels, and molecular mediators. Allergy is your body's reaction to a foreign chemical that isn't damaging to you. Allergens refer to these foreign particles. Reduced exposure to known allergens, as well as the use of antihistamines and steroids, are among the treatments for allergies.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 14: Innate Immunity: Complement and Beyond

Natural (innate) immunity is named after the fact that it is present from birth and does not require learning through infection. As a result, it can react fast to intruders from another planet. On the other hand, its components deal with all extraterrestrial invaders in the same way. They only recognise a restricted number of identifying compounds used by foreign intruders (antigens). On the other hand, these antigens are found on a wide range of invaders. In contrast to acquired immunity, innate immunity has no recollection of the interactions, does not recognise specific foreign antigens, and does not give long-term protection from infection. White blood cells implicated in innate immunity include monocytes (which mature into macrophages), neutrophils, eosinophils, basophils, and natural killer cells. Each category has a certain function. Innate immunity also involves mast cells, the complement system, and cytokines.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 15: Maternal-Fetal Newborn Immunity

The mother's immune system is critical for a healthy pregnancy to begin, maintain, and finish. However, the specific techniques used to achieve these goals are unknown. The cells and molecules of the immune system play a crucial role in the creation and function of the placenta and the foetus. The effector cells of the immune system simultaneously drive and inhibit placental development. During pregnancy, the immunological shift between T helper 1 (Th1) and T helper 2 (Th2) is well known. We also go over the symptoms of a weaker maternal immune system during pregnancy, such as increased vulnerability to viral, bacterial, and parasite infections.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 16: Myeloid Cells: From Birth to Immunity and Disease

Immune homeostasis, inflammation, and the coordination of complicated disease responses all rely on myeloid cells. We continue to discover how the roles of a variety of myeloid cell types and subsets underpin both beneficial immune responses and unwanted disease, which has long been known to be part of the body's initial responses to infection. We will cover granulopoiesis, intracellular and intercellular communication, regulatory mechanisms, and how these basic biological processes intersect with autoimmune, inflammation, metabolism, and cancer in this Express symposium.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 17: Anaphylaxis and Asthma

Anaphylaxis is a life-threatening allergic reaction triggered by exposure to an allergen such as venom, food, or medication. Asthma is a chronic inflammatory condition of the lungs' airways. Asthma is typically brought on by a combination of hereditary and environmental causes. Air pollution and allergies are examples of environmental influences. Variable and recurring symptoms, reversible airflow blockage, and readily induced bronchospasms are all signs of this condition.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 18: Neuro-Immune Interactions in the Central Nervous System

Neuroinflammatory processes worsen many central nervous system diseases. They include complex interactions between the immune system and brain cells, and are mediated by intrinsic and extrinsic immune effector cells and substances. Furthermore, as study and technology in the field progress, new findings have inspired deeper inquiry into the concepts of neuroimmunology. According to research into Alzheimer's disease, traumatic brain injury (TBI), stroke, and multiple sclerosis, neuroinflammation is a significant component of the central nervous system (CNS) disease trajectory. Genetics, the microbiome, and the blood-brain barrier can all influence multicellular responses to CNS damage and disease. The immune system and the central nervous system (CNS) are now known to communicate actively in order to modify both central and peripheral immune responses.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 19: Food and Drug Allergy

A food allergy is an aberrant immunological response to food or an unpleasant system response to food. Cow's milk, peanuts, eggs, shellfish, fish, tree nuts, soy, wheat, and rice are common allergen foods. Itching, swelling of the tongue, vomiting, diarrhoea, hives, difficulty breathing, and low blood pressure are all possible symptoms.

A drug allergy is an immune system reaction to a medication that is aberrant. The majority of people are allergic to penicillin and other antibiotics. Sulfa medications, barbiturates, and anti-seizure drugs are among the other pharmaceuticals that have been linked to allergies.

• Rashes on the skin

• Itchy skin or eyes

• Inflammation of the mouth and throat

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 20: Neonatal and Pediatric Immunology

The system, like many other systems in the body, isn't entirely functional at birth, putting us at danger of infection. In comparison to adults, youth have a weaker immunological response. Increased susceptibility to infections and lower responses to immunizations that are effective in adults arise from immune system depletion. Allergies, autoimmune diseases, primary immune deficiency disorders, and acquired deficiency disorders are all common in children's immunology.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 21: Positive-Strand RNA Viruses

The way viruses store their genomic information, which can be either DNA or double-stranded RNA, distinguishes them. One example is positive-sense single-stranded RNA (+ssRNA) viruses, which constitute a crucial aspect of the virus's infectious cycle. Hepatitis A and Serious Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are two +ssRNA viruses that cause coronavirus and hepatitis A, respectively. Positive-strand RNA viruses are a group of viruses that have single-stranded, positive-sense ribonucleic acid genomes. The positive-sense genome can act as messenger RNA (mRNA) and be translated into viral proteins directly by the host cell's ribosomes.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

Session 22: Oral Allergy Syndrome

Oral Allergy Syndrome is a form of food allergy characterised by an accumulation of allergic reactions in the mouth and throat as a result of eating specific fruits, nuts, and vegetables. It is most common in adults with hay fever. OAS can strike at any time of year, but it is more common during pollen season. OAS patients typically experience symptoms within minutes of ingesting the dish. Allergic reactions in OAS sufferers frequently happen quickly, within minutes of ingesting a trigger food.

Associated Conferences

Related Associations

Associated Journals

Associated Societies

About Conference

We are delighted to welcome a warm welcome to the “6^th International Congress on Allergy and Clinical Immunology” conference on March 27-29, 2023 in London, UK which includes quick presentation posters , presentations and presentations, a youth research forum and more. The conference was organized around the theme “Evolving the cutting edge issues in Allergy and Clinical Immunology” Clinical Immunology conferences 2023 shares an overview of recent research and cutting-edge technologies in the immune system, gaining wide interest and a large presence of experts.

The purpose of Clinical Immunology conferences 2023 is to bring together multidisciplinary scientists and professionals from all over the world to showcase and exchange innovative ideas related to immunology and allergy. It promotes the globalization of high-level research and overall quality research, thereby making discussions and presentations more internationally competitive, and paying attention to the latest outstanding achievements in the field of immunology and future trends and needs. The conference covered clinical immunology and global aspects of allergic diseases.

Why Clinical Immunology conferences 2023?

It promotes superior research, focusing on outstanding contemporary achievements in the field of immunology, as well as future trends and needs. Share insights into recent immune system research and technology.
Discuss the need for improvements to simplify allergy and immunology.
Clinical Immunology conferences 2023 will host the platform to meet with world leaders in the field of immunology and hear their research.
Global Organization: Exchange and Trade Ideas at this scientific conference. This is a great opportunity to showcase your ideas and share your valuable knowledge.
Best Poster Presentation and Scientist Award.

Why To attend??

Meet experts and influencers in Clinical Immunology conferences 2023. The goal of the conference is to discuss, disseminate and preserve knowledge in Clinical Immunology and Allergic Diseases.It gives innovators the opportunity to bridge the gap between development and adoption. At this three-day event, you can give presentations, disseminate information, meet current and potential scientists, gain attention with new discoveries in Clinical Immunology and gain fame . Participants will have direct access to a select group of experts and decision makers

Target Audience:

Allergists
Immunologists
Cellular biologists
Molecular biologists
Biochemists
Biotechnologists
Pulmonologists
Microbiologists
Pathologists
Bioinformaticians
Physician
Paediatricians
Immunology professionals
Allergy specialists
Infectious diseases treatment doctors
University Professors
Research Scholars
Laboratory technicians
Students

Past Conference Report

Clinical Immunology 2022 also took the privilege of felicitating Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs, Young Researchers, and other attendees whose support made the conference a great success and a memorable event.

PULSUS Conferences successfully completed the 5^th International Conference on Clinical Immunology and Allergic diseases organised during May 02, 2022, as a Webinar.

The conference was organized around the theme Advances in the treatment of Immune and Allergic Diseases. The list of sessions discussed were Clinical Immunology, COVID-19-Pandemic diseases, Allergy and Inflammation, Immune Disorders, Neonatal and Pediatric Immunology, Autoimmune diseases and HIV, Vaccination and Immunisation, Market and Future of Therapeutics and more.

With the grand success of the event, we are glad to announce our next upcoming conference “6^th International Congress on Allergy and Clinical Immunology” Scheduled on March 27-29, 2023, in London,UK.

Join us on Clinical Immunology conferences 2023!

6th International Congress on
Allergy and Clinical Immunology

Quick Links

Theme: Evolving the cutting edge issues in Allergy and Clinical Immunology

Conference Information

Welcome Message

Market Analysis

Scientific Tracks

About Conference

View Proceedings of Previous Conferences